Cost and effectiveness of the California triple marker prenatal screening program

This publication has 15 references indexed in Scilit:

• Economic assessment of maternal serum screening for Down's syndrome using human chorionic gonadotropin
  Prenatal Diagnosis, 1993
• Appraisal of a new scheme for prenatal screening for Down's syndrome.
  BMJ, 1991
• Cost-Justification Analysis of Prenatal Maternal Serum Alpha-feto Protein Screening
  Medical Care, 1988
• Maternal serum screening for Down's syndrome in early pregnancy.
  BMJ, 1988
• An economic appraisal of screening for Down's syndrome in pregnancy using maternal age and serum alpha fetoprotein concentration
  Social Science & Medicine, 1987
• Maternal serum alpha-fetoprotein screening for neural tube defects. Results of a consensus meeting
  Prenatal Diagnosis, 1985
• Estimating an individual's risk of having a fetus with open spina bifida and the value of repeat alpha-fetoprotein testing: FOURTH REPORT OF THE UK COLLABORATIVE STUDY ON ALPHA-FETOPROTEIN IN RELATION TO NEURAL TUBE DEFECTS
  Journal of Epidemiology and Community Health, 1982
• A cost-benefit analysis of prenatal detection of down syndrome and neural tube defects in older mothers
  American Journal of Medical Genetics, 1981
• Preventing the birth of infants with Down's syndrome: a cost-benefit analysis.
  BMJ, 1976
• PRENATAL DIAGNOSIS OF SPINA BIFIDA AND ANENCEPHALY THROUGH MATERNAL PLASMA-ALPHA-FETOPROTEIN MEASUREMENT
  The Lancet, 1974